Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Athersys Inc (NASDAQ:ATHX)

1.55
Delayed Data
As of Jun 23
 -0.03 / -1.90%
Today’s Change
1.02
Today|||52-Week Range
2.35
+1.31%
Year-to-Date
No recent news for Athersys Inc.

Today’s Trading

Previous close1.58
Today’s open1.60
Day’s range1.52 - 1.60
Volume1,064,418
Average volume (3 months)1,139,702
Market cap$172.5M
Dividend yield--
Data as of 3:59pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)+10.00%
Earnings growth (this year)-42.59%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+45.19%
P/E ratioNM
Price/Sales7.47
Price/Book12.01

Competitors

 Today’s
change
Today’s
% change
FOMXFoamix Pharmaceutica...+0.14+3.10%
PPHMPeregrine Pharmaceut...-0.01-1.53%
STDYSteadymed Ltd+0.10+1.52%
KURAKura Oncology Inc-0.05-0.63%
Data as of 4:00pm ET, 06/23/2017

Financials

Next reporting dateAugust 14, 2017
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$17.3M
Annual profit (last year)-$15.3M
Net profit margin-88.41%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Gil van Bokkelen
President, Chief Operating Officer &
Secretary
William B. J. Lehmann
Corporate headquarters
Cleveland, Ohio

Forecasts